Biocon Limited (BIOCON) partners with Duopharma Biotech to secure insulin contracts in Malaysia, valued at over MYR 225 million.
Supriya Lifescience Limited (NSE: SUPRIYA) stock price moves up 5% intraday to ₹974.0, extending gains in the Healthcare » Biotechnology sector.
Panacea Biotec Limited (NSE: PANACEABIO) launches DE NSTAR project to advance dengue vaccine DengiA/1 licensure in Sub-Saharan Africa.
Shilpa Medicare Limited (NSE: SHILPAMED) acquires 30.4% stake in Gate2Brain to advance brain cancer therapy.
Supriya Lifescience Limited (SUPRIYA) reports a 50% YoY revenue surge in Q4 FY26, driven by strong performance across therapeutic segments.
Blue Jet Healthcare Limited (BLUEJET) reported a 22% QoQ increase in revenue for Q4 FY26, with PAT rising by 60%.
Zota Health Care Limited (ZOTA) reports strong FY26 results with revenue up 83.86% YoY, EBITDA at ₹2,597.73 lakhs, and expansion to 2,579 stores.
Take Solutions Limited (NSE: TAKE) reports a strong financial performance for FY26 with ₹6,087 Lakhs consolidated total income.
Glenmark Pharmaceuticals Limited announces new development candidate ISB 2301, a first-in-class multispecific immune cells activator targeting solid tumors.
Dishman Carbogen Amcis Limited (DCAL) reports a 18.9% revenue increase in Q4 FY26, driven by growth in CDMO and Marketable Molecules segments.